Pharma & Bio

Latest Content

Industry Update

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Analysis

Case study: New cleanrooms prompt search for better monitoring system

During preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring…